Skip to content
akaturk Academic measurement

Article detail · 2024 · article

Evaluation of COVID-19 Patients Who Developed after COVID-19 Vaccination

Journal Journal of Biotechnology and Strategic Health Research
ISSN2587-1641
YÖKSİS OpenAlex Open access · diamond
Year2024
Citations0OpenAlex
Percentile%13.0
FWCI0.01.00 = world average

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueJournal of Biotechnology and Strategic Health Research
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

Aim: The aim of this study is to evaluate the sociodemographic and clinical characteristics of patients with COVID-19 that developed after COVID-19 vaccination. Material and Method: The study was conducted at a state hospital between July 5 and August 5, 2021. Patients who received COVID-19 vaccine, whose SARS-CoV-2 positivity was confirmed by molecular methods, and who were hospitalized for COVID-19 were included. Sociodemographic information and clinical observation results of patients were recorded. Results: 49.09% of the patients were female and the median age was 72.00 [62.00-79.00] years. 70.45% of patients had a chronic disease and 37.27% were constantly using medication. 82.73% of patients received the CoronaVac vaccine and 8.18% received COVID-19 mRNA vaccine; 9.09% had received both vaccines. 66.82% of patients received two doses of COVID-19 vaccine, 26.82% received three doses, 5.45% received one dose and 0.91% received four doses of COVID-19 vaccine. When the infection findings at the time of admission to the hospital are evaluated, the most common symptoms in patients are dyspnea (89.55%), cough (45.45%), weakness (37.73%), malaise (22.27%) and fatigue-exhaustion. (20.00%); 95% of them had COVID-19 findings in their lung imaging reports. 99.55% of patients receive oxygen therapy; 62.73% were connected to mechanical ventilation. 91.82% of patients were receiving steroid treatment, 89.09% were receiving faviripavir treatment, and 98.64% were receiving anticoagulant; 96.82% had received antibiotic treatment. 38.64% of patients were discharged; 61.36% died. Conclusion: It has been observed that the average age of patients who contracted COVID-19 disease after the COVID-19 vaccine was high, they had a high rate of chronic disease, they were vaccinated with hight rate CoronaVac vaccine, and they received a maximum of two doses of vaccine and they did not receive a reminder dose. Mortality and morbidity can be reduced by creating successful vaccination programs as well as protective measures in the fight against COVID-19.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

0citationsOpenAlex · cited_by_count (cache / database)

Authors

8
  1. GÜLSÜM KAYA 1
  2. Pınar Özkan Oskay 2
  3. NESRİN KEBABCI MERT 3
  4. ŞEYMA TRABZON 4
  5. ZEYNEP ERGENÇ YALOVA ÜNİVERSİTESİ 5
  6. HASAN ERGENÇ 6
  7. OSMAN KARAKUŞ 7
  8. CENGİZ KARACAER 8